Theproduction of radiopharmaceuticals as compared to traditional pharmaceuticalsis a multifaceted procedure and requires specialized facilities, equipment andoperational expertise. Further, owing to its inherent hazardous nature,radiopharmaceuticals have a complex regulatory market authorization process.Consequently, a number of innovator companies have demonstrated a preferencefor outsourcing radiopharmaceutical manufacturing to contract serviceproviders.
RootsAnalysis is pleased to announce the publication of its recent study, titled, “Nuclear Medicine andRadiopharmaceuticals Manufacturing Market, 2020-2030”
TheUSD 6+ billion (by 2030) financial opportunity associated with nuclear medicineand radiopharmaceuticals manufacturing, has been analyzed across the followingsegments:
TargetDisease Indication
· Breast Cancer
· Chronic Lymphocytic Leukemia
· Colorectal Cancer
· Head and Neck Cancer
· Lung Cancer
· Lupus Nephritis
· Melanoma
· Multiple Myeloma
· Primary Sjögren's Syndrome
· Others
TargetImmune Checkpoint
· B7-H3
· CD38
· CD40
· CD47
· Others
Mechanismof Action
· Inhibitory
· Stimulatory
TherapeuticModality
· Monoclonal Antibody
· Small Molecule
Typeof Therapy
· Monotherapy
· Combination Therapy
Routeof Administration
· Intravenous
· Subcutaneous
· Others
KeyGeographical Regions
· North America
· Europe
· Asia-Pacific and the Rest of the World
TheNuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030 reportfeatures the following companies, which we identified to be key players in thisdomain:
· Advanced Accelerator Applications
· Belgian Nuclear Research Center (SCK•CEN)
· Cardinal Health
· China Isotope & Radiation Corporation
· Curium Pharma
· DuChemBio
· Eckert & Ziegler
· Eczacibasi-Monrol
· GE Healthcare
· Jubilant DraxImage
· Lantheus Medical Imaging
· Nihon Medi-Physics
· Nordion
· PETNET Solutions
· SinoTau Pharmaceuticals
· SOFIE
Tableof Contents
1. Preface
2. Executive Summary
3. Introduction
4. Nuclear Medicine andRadiopharmaceuticals Manufacturers (Industry Players): Current Market Landscape
5. Nuclear Medicine andRadiopharmaceuticals Manufacturers (Non-Industry Players): Current MarketLandscape
6. Nuclear Medicine andRadiopharmaceuticals Manufacturers in North America
7. Nuclear Medicine andRadiopharmaceuticals Manufacturers in Europe
8. Nuclear Medicine andRadiopharmaceuticals Manufacturers in Asia-Pacific And Rest of The World
9. Nuclear Medicine andRadiopharmaceuticals Manufacturers: Company Competitiveness Analysis
10. Partnerships andCollaborations
11. Production and SupplyChain of Medical Isotope Molybdenum-99 (Technetium-99m)
12. Market Forecast andOpportunity Analysis
13. Concluding Remarks
14. Executive Insights
15. Appendix 1: TabulatedData
16. Appendix 2: List ofCompanies and Organizations
Formore information, please click on the following link:
https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html
AboutRoots Analysis
RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
ContactInformation
RootsAnalysis Private Limited
GauravChaudhary
+1(415) 800 3415
